Premium Information is available for this item - Upgrade for $1 a day

6505-01-282-2970

Usp Cimetidine Hydrochloride Injection

6505012822970 012822970 NDC00108-5022-16 TAGAMENT TAGAMENT INJECTION

INC: 66557 Cimetidine Hydrochloride Injection

Managed by United States

NSN Created on 13 Jul 1988

Data Last Changed
June 2023

NATO Update Count
8

NATO Data Quality

6505-01-282-2970 CIMETIDINE HYDROCHLORIDE INJECTION,USP 6505012822970 012822970 1/1 — NSN 6505-01-282-2970 (Generic Image) 1/1

Marketplace 6505-01-282-2970

Need Help?
Request a Quotation from participating marketplace vendors

Updated Every Day

6505-01-282-2970 RQST NE

Updated Every Day

6505-01-282-2970 RQST

Updated Every Day

6505-01-282-2970 RQST NE

Related Documents 6505-01-282-2970 5+ Documents (More...)

https//www.nsnlookup.com
/fsg-65/fsc-6505/us

6505-01-282-2970 Usp Cimetidine Hydrochloride Injection

NDC00108-5022-16 TAGAMENT TAGAMENT INJECTION Managed by United States NSN Created on 13 Jul 1988 Data
6505-01-282-2970 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-282-2970
) Canceled/Obsolete RNCC 5 RNVC 9 DAC 4 TAGAMENT INJECTION 93544 - Glaxosmithkline Holdings https//www.nsnlookup.com

https//www.nsnlookup.com
/fsg-65/fsc-6505/us

6505-01-051-4698 Usp Cimetidine Hydrochloride Injection

Documents 6505-01-051-4698 5+ Documents ( More https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-282-2970
Usp Cimetidine Hydrochloride Injection Usp Cimetidine Hydrochloride Injection TAGAMENT https//www.nsnlookup.com
Injection Documents 6505-01-051-4698 5+ Documents ( More https//www.nsnlookup.com -65/fsc-6505/us 6505-01-282-2970

https//www.nsnlookup.com
/fsg-65/fsc-6505/us

6505-01-292-5620 Usp Cimetidine Hydrochloride Injection

Cimetidine Hydrochloride Injection -1661 https NATO Stock Numbers Related to 6505-01-051-4698 6505-01-282-2970
6505-01-292-5620 https//www.nsnlookup.com /fsg-65 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-282-2970
Usp Cimetidine Hydrochloride Injection www.nsnlookup.com -65/fsc-6505/us 6505-01-282-2970 https

https//www.nsnlookup.com
/fsg-65/fsc-6505/us

6505-01-069-1661 Usp Cimetidine Hydrochloride Injection

6505-01-069-1661 /fsg-65/fsc-6505/us 6505-01-292-5620 Usp Cimetidine Hydrochloride Injection 6505-01-282-2970
6505-01-069-1661 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-282-2970 Usp Cimetidine Hydrochloride
Injection NATO Stock Numbers Related to 6505-01-282-2970 https//www.nsnlookup.com /fsg-65/fsc-6505/us

https//www.nsnlookup.com
/fsg-65/fsc-6505/us

6505-01-156-2301 Cimetidine Hydrochloride Injecti 011562301

Hydrochloride Injecti 011562301 051-4698 https Related Documents 6505-01-156-2301 https Injection 6505-01-282-2970
2301 RQST NE Related Documents 6505-01-156-2301 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-282-2970
Usp Cimetidine Hydrochloride Injection Related to 6505-01-051-4698 6505-01-282-2970 https https

Restrictions 6505-01-282-2970

6505-01-282-2970 is a Usp Cimetidine Hydrochloride Injection that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.

Import and Export 6505-01-282-2970

Schedule B: Subscribe to View Schedule B
HTS Code: Subscribe to View HTS Code

End Users 6505-01-282-2970

MOE Rule:: V542
Effective Date:: 1 Apr 1991; AMC 0 AMSC 0

Approved Sources 6505-01-282-2970

Part Number
Manufacturer
Status
NDC00108-5022-16: 93544 - Glaxosmithkline Holdings (Americas) (Obsolete); Original Design; RNCC 3 RNVC 9 DAC 6
TAGAMENT: 93544 - Glaxosmithkline Holdings (Americas) (Obsolete); Canceled/Obsolete; RNCC 5 RNVC 9 DAC 4
TAGAMENT INJECTION: 93544 - Glaxosmithkline Holdings (Americas) (Obsolete); Canceled/Obsolete; RNCC 5 RNVC 9 DAC 4

Datasheet 6505-01-282-2970

Characteristic
Specifications
FIIG: A45100
Active Medicament Medicinal Strength [AKJA]: 150Mg. Cimetidine Equivalent Per Ml.
Pharmaceutical Vehicle Type [AKJQ]: Fluorinated Hydrocarbon
Administration [CSGS]: Intravenous
Primary Container Type [CQCT]: Vial, Multiple Dose
Primary Container Content Quantity [CRLK]: 8.000 Milliliters
Total Primary Container Quantity [CSCW]: 25
Part Name Assigned By Controlling Agency [CXCY]: Cimetidine Hydrochjloride Injection 8Ml Vial 25S

Management Data 6505-01-282-2970

Subscribe
View Prices

Effective Date: Organization; Unit of Issue; Unit Price; Qty Unit Pack
Nov 1989: Veterans Administration (VA); PG; Subscribe

MOE: USC; Code; Statement; Order of Use; Jump To Code; Qty Per Assy; UOM; Technical Document; Quantative Expression
Veterans Administration (VA): V; K; U/I Contains 25 Ea; 00000000025EA

Similar Supply Items to 6505-01-282-2970

Freight Information 6505-01-282-2970

6505-01-282-2970 has freight characteristics.. 6505-01-282-2970 has a variance between NMFC and UFC when transported by rail and the description should be consulted.